Learn more →
Back to Expert Scholars
clinical / clinicalgastric cancer perioperative chemotherapy

Salah-Eddin Al-Batran

萨拉赫-埃丁·艾尔-巴特兰

MD

🏢Krankenhaus Nordwest, Frankfurt(法兰克福西北医院)🌐Germany

Director, Institute of Clinical Cancer Research临床癌症研究所主任

55
h-index
2
Key Papers
2
Awards
2
Key Contributions

👥Biography 个人简介

Salah-Eddin Al-Batran is a German GI oncologist who developed and validated the FLOT (5-FU/leucovorin, oxaliplatin, docetaxel) perioperative chemotherapy regimen for resectable gastric and gastroesophageal junction cancer. The FLOT4-AIO trial demonstrated superior overall survival compared to the previous ECF/ECX standard, establishing FLOT as the new perioperative chemotherapy standard of care in Europe and increasingly worldwide. Al-Batran has continued to refine perioperative strategies including addition of ramucirumab, nivolumab, and other agents to FLOT, and contributes to FLOT-based clinical trial network in Germany.

Share:

🧪Research Fields 研究领域

FLOT regimen gastricFLOT方案胃癌
perioperative chemotherapy gastric胃癌围手术期化疗
FOLFOX gastricFOLFOX胃癌
German gastric cancer德国胃癌
neoadjuvant therapy GEJGEJ新辅助治疗

🎓Key Contributions 主要贡献

FLOT Regimen Development

Developed and validated FLOT perioperative chemotherapy through FLOT4-AIO trial, demonstrating superior pCR rates and OS compared to ECF/ECX and establishing FLOT as the standard perioperative regimen for resectable gastric/GEJ cancer.

FLOT Combination Development

Led trials adding targeted agents and immunotherapy to FLOT backbone, including ramucirumab, nivolumab, and other combinations to further improve outcomes in resectable gastric cancer.

Representative Works 代表性著作

[1]

Perioperative Chemotherapy with Fluorouracil plus Leucovorin, Oxaliplatin, and Docetaxel versus Fluorouracil or Capecitabine plus Cisplatin and Epirubicin for Locally Advanced Resectable Gastric Cancer (FLOT4)

Lancet (2019)

FLOT4-AIO trial establishing FLOT as standard perioperative regimen.

[2]

FOLFOX in Patients with Metastatic or Locally Advanced Gastric Cancer

Annals of Oncology (2008)

FOLFOX validation in advanced gastric cancer.

🏆Awards & Recognition 奖项与荣誉

🏆German Cancer Society Scientific Award
🏆AGO Excellence in Cancer Research Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 萨拉赫-埃丁·艾尔-巴特兰 的研究动态

Follow Salah-Eddin Al-Batran's research updates

留下邮箱,当我们发布与 Salah-Eddin Al-Batran(Krankenhaus Nordwest, Frankfurt)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment